Here we applied genomic analyses using four TCGA tumor datasets (breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, and colon adenocarcinoma) [22]–[24] to define the mRNA expression signature associated with reduced TTP levels in human malignancies. This evidence concerns the gene ZFP36 and colon adenocarcinoma.